Bioequivalence of two kinds of suitamicillin tablets in healthy human volunteers
Yi Dan, Zuojun Li, Zhou Yu-lu, Huang Qi, Cuifang Wu
Abstract
Yi Dan, Zuojun Li, Zhou Yu-lu, Huang Qi, Cuifang Wu
Abstract
AIM:To study the phamacokinetics and correlative bioavailability and evaluate the bioequiva- lence of two kinds of sultamicillin tablets.METHODS:A random crossover trial was designed.Plasma concen- trations were determined by HPLC method following a single oral dose 750 mg of two different brands suhami- cillin tablets.RESULTS:The ampicillin pharmacokinetic parameters of the test tablets and the reference tablets in plasma were as following: t_(max) were(l.1±s 0.3)vs(1.2±0.4)h;c_(max) were(10±5)vs(11±6)mg·L~(-1);t_(1/2) were(1.8±0.5)vs(1.6±0.4)h;AUC_(0-8) were(22±15)vs(22±15)mg·h·L~(-1),respectively.The ampicillin bioavailability of the test tablets was(100±10)% in correlative with the reference tablets.The sulbactam phar- macokinetic parameters of the test tablets and the reference tablets in plasma were as following:t_(max) were(1.2±0.3)vs(1.3±0.4)h;c_(max) were(5.5±1.2)vs(5.6±1.1)mg·L~(-1);t_(1/2) were(1.5±0.3)vs(1.46±0.28)h; A UC_(0-8) were(10.6±2.1)vs(10.2±1.6)mg·h·L~(-1),respectively.The sulbactam bioavailability of the test tablets was(102±11)% in correlative with the reference tablets.CONCLUSION:The two kinds of sultamicillin tablets are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM:To study the phamacokinetics and correlative bioavailability and evaluate the bioequiva- lence of two kinds of sultamicillin tablets.METHODS:A random crossover trial was designed.Plasma concen- trations were determined by HPLC method following a single oral dose 750 mg of two different brands suhami- cillin tablets.RESULTS:The ampicillin pharmacokinetic parameters of the test tablets and the reference tablets in plasma were as following: t_(max) were(l.1±s 0.3)vs(1.2±0.4)h;c_(max) were(10±5)vs(11±6)mg·L~(-1);t_(1/2) were(1.8±0.5)vs(1.6±0.4)h;AUC_(0-8) were(22±15)vs(22±15)mg·h·L~(-1),respectively.The ampicillin bioavailability of the test tablets was(100±10)% in correlative with the reference tablets.The sulbactam phar- macokinetic parameters of the test tablets and the reference tablets in plasma were as following:t_(max) were(1.2±0.3)vs(1.3±0.4)h;c_(max) were(5.5±1.2)vs(5.6±1.1)mg·L~(-1);t_(1/2) were(1.5±0.3)vs(1.46±0.28)h; A UC_(0-8) were(10.6±2.1)vs(10.2±1.6)mg·h·L~(-1),respectively.The sulbactam bioavailability of the test tablets was(102±11)% in correlative with the reference tablets.CONCLUSION:The two kinds of sultamicillin tablets are bioequivalent.
Key concepts: Bioequivalence, Bioavailability, Pharmacokinetics, Plasma concentration, Crossover study, Chemistry, Chromatography, Pharmacology